{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:17:15Z","timestamp":1787015835305,"version":"build-2736575974"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T00:00:00Z","timestamp":1386028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The endogenous cannabinoid system (\n                      <jats:styled-content style=\"fixed-case\">ECS<\/jats:styled-content>\n                      ) plays a crucial role in multiple physiological processes in the central nervous system and in the periphery. The discovery that selective cannabinoid (\n                      <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content>\n                      ) receptor agonists exert a potent inhibitory action on gastrointestinal (\n                      <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content>\n                      ) motility and pain has placed the\n                      <jats:styled-content style=\"fixed-case\">ECS<\/jats:styled-content>\n                      in the center of attention as a possible target for the treatment of functional\n                      <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content>\n                      diseases. However, side effects of\n                      <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content>\n                      agonists prompted the search for novel therapeutic targets. Here, the effect of\n                      <jats:styled-content style=\"fixed-case\">PF<\/jats:styled-content>\n                      \u20103845, a potent and selective fatty acid amide hydrolase (\n                      <jats:styled-content style=\"fixed-case\">FAAH<\/jats:styled-content>\n                      ) inhibitor in the\n                      <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content>\n                      tract was investigated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The effect of\n                      <jats:styled-content style=\"fixed-case\">PF<\/jats:styled-content>\n                      \u20103845 on\n                      <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content>\n                      motility was characterized in vitro and in vivo, using mouse models that mimic physiological and pathophysiological conditions. The antinociceptive action of\n                      <jats:styled-content style=\"fixed-case\">PF<\/jats:styled-content>\n                      \u20103845 was evaluated on the basis of behavioral pain models. Endocannabinoid degradation product levels after inhibition of\n                      <jats:styled-content style=\"fixed-case\">FAAH<\/jats:styled-content>\n                      were quantified using\n                      <jats:styled-content style=\"fixed-case\">HPLC<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">PF<\/jats:styled-content>\n                      \u20103845 significantly inhibited mouse colonic motility in vitro and in vivo. Selective inhibition of\n                      <jats:styled-content style=\"fixed-case\">FAAH<\/jats:styled-content>\n                      reversed hypermotility and reduced pain in mouse models mimicking functional\n                      <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content>\n                      disorders. The effects of\n                      <jats:styled-content style=\"fixed-case\">PF<\/jats:styled-content>\n                      \u20103845 were mediated by endogenous\n                      <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content>\n                      s and non\u2010\n                      <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content>\n                      lipophilic compounds via classical (\n                      <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content>\n                      1) and atypical\n                      <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content>\n                      receptors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions &amp; Inferences<\/jats:title>\n                    <jats:p>\n                      These data expand our understanding of the\n                      <jats:styled-content style=\"fixed-case\">ECS<\/jats:styled-content>\n                      function and provide a novel framework for the development of future potential treatments of functional\n                      <jats:styled-content style=\"fixed-case\">GI<\/jats:styled-content>\n                      disorders.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/nmo.12272","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T06:28:45Z","timestamp":1386138525000},"page":"470-481","source":"Crossref","is-referenced-by-count":60,"title":["Selective inhibition of\n                    <scp>FAAH<\/scp>\n                    produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid\u2010like fatty acid amides"],"prefix":"10.1111","volume":"26","author":[{"given":"J.","family":"Fichna","sequence":"first","affiliation":[{"name":"Snyder Institute for Chronic Diseases University of Calgary Calgary AB Canada"},{"name":"Department of Medicine Division of Gastroenterology University of Calgary Calgary AB Canada"},{"name":"Department of Biomolecular Chemistry Faculty of Medicine Medical University of Lodz Lodz Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sa\u0142aga","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Chemistry Faculty of Medicine Medical University of Lodz Lodz Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Stuart","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences Gill Center for Biomolecular Science Indiana University Bloomington IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Saur","sequence":"additional","affiliation":[{"name":"II Medizinische Klinik Technische Universit\u00e4t M\u00fcnchen Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sobczak","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Chemistry Faculty of Medicine Medical University of Lodz Lodz Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zatorski","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Chemistry Faculty of Medicine Medical University of Lodz Lodz Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. \u2010P.","family":"Timmermans","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Biology and Histology Department of Veterinary Sciences University of Antwerp Antwerp Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. B.","family":"Bradshaw","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences Gill Center for Biomolecular Science Indiana University Bloomington IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ahn","sequence":"additional","affiliation":[{"name":"Pfizer Worldwide Research and Development Cambridge MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Storr","sequence":"additional","affiliation":[{"name":"Snyder Institute for Chronic Diseases University of Calgary Calgary AB Canada"},{"name":"Department of Medicine Division of Gastroenterology University of Calgary Calgary AB Canada"},{"name":"Department of Medicine Division of Gastroenterology Ludwig Maximilians University of Munich Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,12,3]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.12.005"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2008.01175.x"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2007.08.008"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1470919"},{"key":"e_1_2_12_6_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator\u2010activated receptor\u2010alpha mediates the anti\u2010inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo VJ","year":"2005","journal-title":"Mol Pharmacol"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-004-4494-0"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.018"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.161191698"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.069401"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.01.022"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706699"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200419465"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706348"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1517\/17460440903018857"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152711796234989"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.200790157"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2009.02.013"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.90274.2008"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12158"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2013.19.1.36"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00444.2004"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2010.04.018"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M606646200"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm803"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.093286"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03658"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/22761"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/28393"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.324"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704220"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01650-3"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01445.x"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2632"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.07.007"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2012.02.012"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2009.59"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2091-10-14"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnmo.12272","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nmo.12272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T12:17:22Z","timestamp":1696508242000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nmo.12272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,3]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.1111\/nmo.12272"],"URL":"https:\/\/doi.org\/10.1111\/nmo.12272","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,3]]}}}